amphetamine has been researched along with Anochlesia in 137 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the suited rat-models, we focused on the stable pentadecapeptide BPC 157, L-NAME, NOS-inhibitor, and L-arginine, NOS-substrate, relation, the effect on schizophrenia-like symptoms." | 8.02 | Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophrenia. ( Balenovic, I; Blagaic, AB; Cilic, M; Drmic, D; Filipcic, I; Ilic, S; Kokot, A; Seiwerth, S; Sikiric, P; Strbe, S; Tvrdeic, A; Vukojevic, J; Zemba Cilic, A; Zemba, M; Zoricic, Z, 2021) |
| "To examine the effects of dehydroepiandrosterone (DHEA) on animal models of schizophrenia." | 7.80 | Effects of dehydroepiandrosterone in amphetamine-induced schizophrenia models in mice. ( Kilic, FS; Kulluk, D; Musmul, A, 2014) |
| "In the suited rat-models, we focused on the stable pentadecapeptide BPC 157, L-NAME, NOS-inhibitor, and L-arginine, NOS-substrate, relation, the effect on schizophrenia-like symptoms." | 4.02 | Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophrenia. ( Balenovic, I; Blagaic, AB; Cilic, M; Drmic, D; Filipcic, I; Ilic, S; Kokot, A; Seiwerth, S; Sikiric, P; Strbe, S; Tvrdeic, A; Vukojevic, J; Zemba Cilic, A; Zemba, M; Zoricic, Z, 2021) |
| "To examine the effects of dehydroepiandrosterone (DHEA) on animal models of schizophrenia." | 3.80 | Effects of dehydroepiandrosterone in amphetamine-induced schizophrenia models in mice. ( Kilic, FS; Kulluk, D; Musmul, A, 2014) |
| "The advantages of BL-1020 for treatment of schizophrenia stem from its being a DA/5HT antagonist and a GABAergic agonist that releases cortical DA and antagonizes amphetamine-induced hyperactivity with reduced catalepsy and sedation." | 3.75 | BL-1020: a novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia. ( Geffen, Y; Gil-Ad, I; Huang, M; Klapper, L; Meltzer, HY; Nudelman, A; Rephaeli, A; Savitsky, K; Weizman, A; Winkler, I, 2009) |
| " Here we dissect the components of dopaminergic neurotransmission in the hyperactive mouse mutant coloboma to identify pre- and postsynaptic elements essential for the effects of amphetamine in these mice." | 3.74 | D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD. ( Fan, X; Hess, EJ, 2007) |
| " However, analysis of the effectiveness of the DA receptor blockade (blockade of d-amphetamine locomotion or DA agonist hypothermia) after intraperitoneal or subcutaneous administration suggested that FLA 797 (-)/FLA 908 (-) may only contribute marginally to the D2 receptor-blocking activity of remoxipride in the rat." | 3.68 | Effects of remoxipride's metabolites on dopamine D2 receptors and receptor functions in the rat. ( Angeby-Möller, K; Hall, H; Ogren, SO; Widman, M, 1993) |
| " The compound antagonized amphetamine-induced stereotyped behavior in rats, amphetamine toxicity in aggregated mice and apomorphine-induced emesis in dogs." | 3.65 | The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug. ( Herr, F; Voith, K, 1975) |
| "HU-556, at high doses, caused catalepsy and hypolocomotion, while HU-502 did not." | 1.91 | Behavioral effects induced by the cannabidiol analogs HU-502 and HU-556. ( Breuer, A; Colodete, DAE; Cortez, I; Del-Bel, EA; Fogaça, MV; Gomes, FV; Guimarães, FS; Mechoulam, R; Pedrazzi, JFC; Silva, NR, 2023) |
| "The extrapyramidal side effect of catalepsy was tested based on the ability of the extracts to alter the duration of akinesia in mice placed on a vertical wrapped string." | 1.38 | Antipsychotic property of aqueous and ethanolic extracts of Lonchocarpus cyanescens (Schumach and Thonn.) Benth. (Fabaceae) in rodents. ( Shonibare, ET; Sonibare, MA; Umukoro, S, 2012) |
| " In addition, the side-effect profile was established by measuring catalepsy, antipsychotic-induced weight gain, plasma levels of prolactin, and anxiogenic potential." | 1.37 | AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents. ( Arad, M; Barak, S; Black, MD; Borowsky, B; Cohen, C; De Levie, A; Featherstone, RE; Giardino, O; Griebel, G; Pichat, P; Rogacki, N; Senyah, Y; Stemmelin, J; Stevens, RJ; Varty, GB; Weiner, I, 2011) |
| "The ability of CCBs to produce catalepsy in mice was also evaluated in the study." | 1.36 | Anti-psychotic and sedative effect of calcium channel blockers in mice. ( Bakre, TO; Onwuchekwa, C; Umukoro, S, 2010) |
| "No changes in haloperidol-induced catalepsy or MK-801-induced locomotion were seen following PD." | 1.35 | Prenatal protein deprivation alters dopamine-mediated behaviors and dopaminergic and glutamatergic receptor binding. ( Brown, AS; Butler, PD; Keegan, D; Palmer, AA; Rotrosen, J; Siska, LD; Susser, E, 2008) |
| "Aripiprazole is an atypical antipsychotic that acts as a partial agonist at the dopamine D(2) receptor." | 1.35 | Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice. ( Guimarães, FS; Leite, JV; Moreira, FA, 2008) |
| "ACP-103 also attenuated catalepsy produced by haloperidol or risperidone." | 1.34 | ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models. ( Anderson, GT; Barido, R; Bonhaus, DW; Brann, MR; Brunmark, P; Davis, RE; Dyssegaard, A; Gardell, LR; Hacksell, U; Johnson, RW; Pounds, L; Tabatabaei, A; Vanover, KE; Veinbergs, I, 2007) |
| "Aripiprazole is a novel antipsychotic drug, which displays partial agonist activity at the dopamine D(2) receptor." | 1.33 | Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties. ( Clarke, K; Davies, CH; Forbes, IT; Gribble, A; Hill, M; Jones, DN; Newson, M; Reavill, C; Rourke, C; Scott, C; Westaway, J; Wood, MD, 2006) |
| "Catalepsy was induced by haloperidol (2 mg/kg p." | 1.33 | Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice. ( Akhtar, M; Ali, A; Pillai, KK; Uma Devi, P; Vohora, D, 2006) |
| " Thus, for example, NT69L after five daily injections at a fixed dosage was as effective at reversing cocaine-induced hyperactivity as after the first injection." | 1.32 | Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier. ( Boules, M; Fauq, A; McCormick, D; McMahon, B; Richelson, E; Stewart, J; Wang, R; Warrington, L; Yerbury, S, 2003) |
| " The application schedule was validated, and the bioavailability of the compound determined, by means of a HPLC-pharmacokinetic study." | 1.32 | FAUC 213, a highly selective dopamine D4 receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia. ( Boeckler, F; Feldon, J; Ferger, B; Gmeiner, P; Hübner, H; Löber, S; Russig, H; Schetz, J; Zhang, W, 2004) |
| "Dopaminergic lesion produced catalepsy and hypoactivity." | 1.32 | Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease. ( Schmidt, WJ; Srinivasan, J, 2004) |
| "Both drugs inhibited catalepsy induced by the dopamine D1-like receptor antagonist R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH23390), the dopamine D2-like receptor antagonist raclopride and by haloperidol, findings in agreement with a dopaminergic effect of cyclooxygenase inhibitors." | 1.31 | Cyclooxygenase inhibitor modulation of dopamine-related behaviours. ( Brooks, RJ; Fletcher, PJ; Kalasinsky, KS; Lee, M; Ross, BM; Seeman, M; Turenne, SD; Vorce, SP, 2002) |
| "The catalepsy was antagonised by dizocilpine and D,L-amphetamine, i." | 1.30 | The mGluRs group II agonist (2S,3S,4S)-alpha-carboxycyclopropyl-glycine induces catalepsy in the rat, which is pronouncedly antagonised by dizocilpine and D,L-amphetamine. ( Kronthaler, UO; Schmidt, WJ, 1998) |
| "Because catalepsy is viewed as an important model for predicting EPS, we decided to re-evaluate the effects of savoxepine." | 1.29 | Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability. ( Donovan, H; Hoffman, DC, 1995) |
| "Ziprasidone also has high affinity for the 5-HT1A, 5-HT1D and 5-HT2C receptor subtypes, which may further enhance its therapeutic potential." | 1.29 | Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. ( Guanowsky, V; Howard, HR; Lebel, LA; Lowe, JA; McLean, S; Schmidt, AW; Schulz, DW; Seeger, TF; Seymour, PA; Zorn, SH, 1995) |
| " Mice and rats were given A5 intraperitoneally at three different dosage levels." | 1.29 | The influence of antineoplaston A5 on the central dopaminergic structures. ( Burzynski, SR; Chodkowska, A; Feldo, M; Juszkiewicz, M; Kleinrok, Z; Majewska, B, 1994) |
| "Spontaneous locomotor activity and catalepsy were assessed in rats during withdrawal from a schedule of intravenous self-administration of high doses of amphetamine." | 1.29 | Lisuride reduces psychomotor retardation during withdrawal from chronic intravenous amphetamine self-administration in rats. ( Koob, GF; Pulvirenti, L, 1993) |
| "Using the excitotoxic animal model of Huntington's disease, two experimental treatments were evaluated." | 1.28 | Neural grafts and pharmacological intervention in a model of Huntington's disease. ( Ford, LM; Giordano, M; Sanberg, PR; Shipley, MT, 1990) |
| "Pretreatment with metergoline (1." | 1.27 | Block of conditioned avoidance responding in the rat by substituted phenylpiperazines. ( Baldy, WJ; Elgin, RJ; Kesslick, JM; Martin, GE; Mathiasen, JR; Scott, MK; Shank, RP, 1988) |
| "Flupirtine has no local anesthetic activity in mice but some weak effects on the cornea of rabbits." | 1.27 | [General pharmacologic studies on the analgesic flupirtine]. ( Achterrath-Tuckermann, U; Jakovlev, V; Stroman, F; Thiemer, K; von Schlichtegroll, A, 1985) |
| "The effect on catalepsy was the most pronounced." | 1.26 | Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics. ( Arnt, J; Christensen, AV, 1981) |
| "Analgesic-induced catalepsy seems to depend on the presynaptic inhibition of dopaminergic neurotransmission; 3." | 1.26 | Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats. ( Langwiński, R; Malec, D, 1981) |
| "This catalepsy was strongly enhanced by (+)-amphetamine and (-)-ephedrine, but was antagonized by other amphetamine-like drugs." | 1.25 | Effect of some amphetamine analogues on -methyl-p-tyrosine-induced catalepsy in rats. ( Sayers, A; Spencer, PS, 1971) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 73 (53.28) | 18.7374 |
| 1990's | 24 (17.52) | 18.2507 |
| 2000's | 25 (18.25) | 29.6817 |
| 2010's | 12 (8.76) | 24.3611 |
| 2020's | 3 (2.19) | 2.80 |
| Authors | Studies |
|---|---|
| Żmudzka, E | 1 |
| Lustyk, K | 1 |
| Głuch-Lutwin, M | 1 |
| Mordyl, B | 1 |
| Zakrzewska-Sito, A | 1 |
| Mierzejewski, P | 1 |
| Jaśkowska, J | 1 |
| Kołaczkowski, M | 1 |
| Sapa, J | 1 |
| Pytka, K | 1 |
| Colodete, DAE | 1 |
| Silva, NR | 1 |
| Pedrazzi, JFC | 1 |
| Fogaça, MV | 1 |
| Cortez, I | 1 |
| Del-Bel, EA | 1 |
| Breuer, A | 1 |
| Mechoulam, R | 1 |
| Gomes, FV | 1 |
| Guimarães, FS | 2 |
| Zemba Cilic, A | 1 |
| Zemba, M | 1 |
| Cilic, M | 1 |
| Balenovic, I | 1 |
| Strbe, S | 1 |
| Ilic, S | 1 |
| Vukojevic, J | 1 |
| Zoricic, Z | 1 |
| Filipcic, I | 1 |
| Kokot, A | 1 |
| Drmic, D | 1 |
| Blagaic, AB | 1 |
| Tvrdeic, A | 1 |
| Seiwerth, S | 1 |
| Sikiric, P | 1 |
| Ufartes, R | 1 |
| Schneider, T | 1 |
| Mortensen, LS | 1 |
| de Juan Romero, C | 1 |
| Hentrich, K | 1 |
| Knoetgen, H | 1 |
| Beilinson, V | 1 |
| Moebius, W | 1 |
| Tarabykin, V | 1 |
| Alves, F | 1 |
| Pardo, LA | 1 |
| Rawlins, JN | 1 |
| Stuehmer, W | 1 |
| Dzirkale, Z | 1 |
| Rumaks, J | 1 |
| Svirskis, S | 1 |
| Mazina, O | 1 |
| Allikalt, A | 1 |
| Rinken, A | 1 |
| Jekabsons, K | 1 |
| Muceniece, R | 1 |
| Klusa, V | 1 |
| Lapish, CC | 1 |
| Ahn, KC | 1 |
| Chambers, RA | 1 |
| Ashby, DM | 1 |
| Ahn, S | 1 |
| Phillips, AG | 1 |
| Kilic, FS | 1 |
| Kulluk, D | 1 |
| Musmul, A | 1 |
| Su, P | 1 |
| Li, S | 1 |
| Chen, S | 1 |
| Lipina, TV | 1 |
| Wang, M | 1 |
| Lai, TK | 1 |
| Lee, FH | 1 |
| Zhang, H | 1 |
| Zhai, D | 1 |
| Ferguson, SS | 1 |
| Nobrega, JN | 2 |
| Wong, AH | 1 |
| Roder, JC | 1 |
| Fletcher, PJ | 2 |
| Liu, F | 1 |
| White, W | 1 |
| White, IM | 1 |
| Natesan, S | 1 |
| Reckless, GE | 1 |
| Barlow, KB | 1 |
| Odontiadis, J | 1 |
| Baker, GB | 1 |
| George, SR | 1 |
| Mamo, D | 1 |
| Kapur, S | 1 |
| Sevak, RJ | 1 |
| Koek, W | 1 |
| Owens, WA | 1 |
| Galli, A | 1 |
| Daws, LC | 1 |
| France, CP | 1 |
| Palmer, AA | 1 |
| Brown, AS | 1 |
| Keegan, D | 1 |
| Siska, LD | 1 |
| Susser, E | 1 |
| Rotrosen, J | 1 |
| Butler, PD | 1 |
| Geffen, Y | 1 |
| Nudelman, A | 1 |
| Gil-Ad, I | 1 |
| Rephaeli, A | 1 |
| Huang, M | 1 |
| Savitsky, K | 1 |
| Klapper, L | 1 |
| Winkler, I | 1 |
| Meltzer, HY | 1 |
| Weizman, A | 1 |
| Marchese, G | 1 |
| Casu, G | 1 |
| Casti, P | 1 |
| Spada, GP | 1 |
| Pani, L | 1 |
| Boulay, D | 1 |
| Bergis, O | 1 |
| Avenet, P | 1 |
| Griebel, G | 2 |
| Ardayfio, PA | 1 |
| Leung, A | 1 |
| Park, J | 1 |
| Hwang, DY | 1 |
| Moran-Gates, T | 1 |
| Choi, YK | 1 |
| Carlezon, WA | 1 |
| Tarazi, FI | 1 |
| Kim, KS | 1 |
| Black, MD | 1 |
| Stevens, RJ | 1 |
| Rogacki, N | 1 |
| Featherstone, RE | 1 |
| Senyah, Y | 1 |
| Giardino, O | 1 |
| Borowsky, B | 1 |
| Stemmelin, J | 1 |
| Cohen, C | 1 |
| Pichat, P | 1 |
| Arad, M | 1 |
| Barak, S | 1 |
| De Levie, A | 1 |
| Weiner, I | 1 |
| Varty, GB | 1 |
| Sonibare, MA | 1 |
| Umukoro, S | 2 |
| Shonibare, ET | 1 |
| Mahmood, D | 1 |
| Khanam, R | 1 |
| Pillai, KK | 2 |
| Akhtar, M | 2 |
| Bakre, TO | 1 |
| Onwuchekwa, C | 1 |
| Ross, BM | 1 |
| Brooks, RJ | 1 |
| Lee, M | 1 |
| Kalasinsky, KS | 1 |
| Vorce, SP | 1 |
| Seeman, M | 1 |
| Turenne, SD | 1 |
| Zhao, H | 1 |
| He, X | 1 |
| Thurkauf, A | 1 |
| Hoffman, D | 1 |
| Kieltyka, A | 1 |
| Brodbeck, R | 1 |
| Primus, R | 1 |
| Wasley, JW | 1 |
| Bajaj, K | 1 |
| Srivastava, VK | 1 |
| Kumar, A | 1 |
| BILY, J | 1 |
| JANSSEN, PA | 5 |
| NIEMEGEERS, CJ | 3 |
| SCHELLEKENS, KH | 2 |
| FUJIMORI, H | 1 |
| COBB, DP | 1 |
| Boules, M | 1 |
| McMahon, B | 1 |
| Wang, R | 1 |
| Warrington, L | 1 |
| Stewart, J | 1 |
| Yerbury, S | 1 |
| Fauq, A | 1 |
| McCormick, D | 1 |
| Richelson, E | 1 |
| Boeckler, F | 1 |
| Russig, H | 1 |
| Zhang, W | 1 |
| Löber, S | 1 |
| Schetz, J | 1 |
| Hübner, H | 1 |
| Ferger, B | 1 |
| Gmeiner, P | 1 |
| Feldon, J | 1 |
| Srinivasan, J | 1 |
| Schmidt, WJ | 3 |
| Levant, B | 1 |
| Radel, JD | 1 |
| Carlson, SE | 1 |
| Dall'Igna, OP | 1 |
| Tort, AB | 1 |
| Souza, DO | 1 |
| Lara, DR | 2 |
| Uma Devi, P | 1 |
| Ali, A | 1 |
| Vohora, D | 1 |
| Wood, MD | 1 |
| Scott, C | 1 |
| Clarke, K | 1 |
| Westaway, J | 1 |
| Davies, CH | 1 |
| Reavill, C | 1 |
| Hill, M | 1 |
| Rourke, C | 1 |
| Newson, M | 1 |
| Jones, DN | 1 |
| Forbes, IT | 1 |
| Gribble, A | 1 |
| Fan, X | 1 |
| Hess, EJ | 1 |
| Gardell, LR | 1 |
| Vanover, KE | 1 |
| Pounds, L | 1 |
| Johnson, RW | 1 |
| Barido, R | 1 |
| Anderson, GT | 1 |
| Veinbergs, I | 1 |
| Dyssegaard, A | 1 |
| Brunmark, P | 1 |
| Tabatabaei, A | 1 |
| Davis, RE | 1 |
| Brann, MR | 1 |
| Hacksell, U | 1 |
| Bonhaus, DW | 1 |
| Stasi, MA | 1 |
| Di Serio, S | 1 |
| Vertechy, M | 1 |
| Schiavone, A | 1 |
| Ghirardi, O | 1 |
| Minetti, P | 1 |
| Campiani, G | 1 |
| Borsini, F | 1 |
| Carminati, P | 1 |
| Leite, JV | 1 |
| Moreira, FA | 1 |
| Pissios, P | 1 |
| Frank, L | 1 |
| Kennedy, AR | 1 |
| Porter, DR | 1 |
| Marino, FE | 1 |
| Liu, FF | 1 |
| Pothos, EN | 1 |
| Maratos-Flier, E | 1 |
| Owolabi, AR | 1 |
| Akanmu, MA | 1 |
| Ukponmwan, OE | 1 |
| Björkman, S | 1 |
| Lewander, T | 1 |
| Zetterström, T | 1 |
| Arnt, J | 3 |
| Christensen, AV | 2 |
| Greenblatt, EN | 2 |
| Coupet, J | 1 |
| Rauh, E | 1 |
| Szucs-Myers, VA | 1 |
| Havemann, U | 1 |
| Malec, D | 2 |
| Langwiński, R | 1 |
| Davidson, AB | 1 |
| Boff, E | 1 |
| MacNeil, DA | 1 |
| Wenger, J | 1 |
| Cook, L | 1 |
| Costall, B | 3 |
| Dannenburg, WN | 1 |
| Johnson, DN | 1 |
| Naylor, RJ | 4 |
| Hyttel, J | 2 |
| Banning, JW | 1 |
| Uretsky, NJ | 1 |
| Patil, PN | 1 |
| Beal, JL | 1 |
| Pycock, C | 2 |
| Dawbarn, D | 1 |
| O'Shaughnessy, C | 1 |
| Hoffman, DC | 1 |
| Donovan, H | 1 |
| Ossowska, K | 1 |
| Seeger, TF | 2 |
| Seymour, PA | 2 |
| Schmidt, AW | 2 |
| Zorn, SH | 2 |
| Schulz, DW | 1 |
| Lebel, LA | 1 |
| McLean, S | 1 |
| Guanowsky, V | 1 |
| Howard, HR | 2 |
| Lowe, JA | 2 |
| Pawłowski, M | 1 |
| Drabczyńska, A | 1 |
| Gorczyca, M | 1 |
| Modzelewski, J | 1 |
| Batatinha, MJ | 1 |
| de Souza-Spinosa, H | 1 |
| Bernardi, MM | 1 |
| Juszkiewicz, M | 1 |
| Chodkowska, A | 1 |
| Burzynski, SR | 1 |
| Feldo, M | 1 |
| Majewska, B | 1 |
| Kleinrok, Z | 3 |
| Migler, BM | 1 |
| Warawa, EJ | 1 |
| Malick, JB | 1 |
| Nisoli, E | 1 |
| Tonello, C | 1 |
| Imhof, R | 1 |
| Scherschlicht, R | 1 |
| da Prada, M | 1 |
| Carruba, MO | 1 |
| Ogren, SO | 1 |
| Hall, H | 1 |
| Widman, M | 1 |
| Angeby-Möller, K | 1 |
| Pulvirenti, L | 1 |
| Koob, GF | 1 |
| Maloney, PR | 1 |
| Ewing, FE | 1 |
| Newman, ME | 1 |
| Furman, JS | 1 |
| Robinson, GL | 1 |
| Jackson, E | 1 |
| Johnson, C | 1 |
| Morrone, J | 1 |
| Borlongan, CV | 1 |
| Cahill, DW | 1 |
| Sanberg, PR | 2 |
| Kronthaler, UO | 2 |
| Nielsen, EB | 2 |
| Hansen, JB | 1 |
| Grłnvald, FC | 1 |
| Swedberg, MD | 1 |
| Scheideler, M | 1 |
| Costa-Campos, L | 1 |
| Nunes, DS | 1 |
| Elisabetsky, E | 1 |
| Cadoni, C | 1 |
| Di Chiara, G | 1 |
| Homan, EJ | 1 |
| Copinga, S | 1 |
| Unelius, L | 1 |
| Jackson, DM | 1 |
| Wikström, HV | 1 |
| Grol, CJ | 1 |
| Khisti, RT | 2 |
| Chopde, CT | 2 |
| Abraham, E | 1 |
| Sieklucka-Dziuba, M | 1 |
| Gustaw, K | 1 |
| Dziuba, J | 1 |
| Betancur, C | 1 |
| Lépée-Lorgeoux, I | 1 |
| Cazillis, M | 1 |
| Accili, D | 1 |
| Fuchs, S | 1 |
| Rostène, W | 1 |
| Hertel, P | 1 |
| Byskov, L | 1 |
| Didriksen, M | 1 |
| Deshpande, LS | 1 |
| Lippa, AS | 1 |
| Osterberg, AC | 1 |
| Funderburk, WH | 1 |
| Leonard, CA | 1 |
| Bhattacharya, SK | 2 |
| Bose, R | 2 |
| Ghosh, P | 1 |
| Tripathi, VJ | 1 |
| Ray, AB | 1 |
| Dasgupta, B | 1 |
| Poddubiuk, ZM | 1 |
| Lal, H | 1 |
| Gianutsos, G | 1 |
| Puri, SK | 1 |
| Kuczenski, R | 1 |
| Schmidt, D | 1 |
| Leith, N | 1 |
| Muller, P | 2 |
| Seeman, P | 2 |
| Korczyn, AD | 1 |
| Nadler, E | 1 |
| Dreyfuss, D | 1 |
| Nielsen, IM | 1 |
| Boeck, V | 1 |
| Danneskiold-Samsoe, P | 1 |
| Langeland, J | 1 |
| Pedersen, V | 2 |
| Svendsen, O | 1 |
| Setler, P | 1 |
| Sarau, H | 1 |
| McKenzie, G | 1 |
| Fog, R | 5 |
| Voith, K | 1 |
| Herr, F | 1 |
| Andersen, PH | 1 |
| Bechara, A | 1 |
| van der Kooy, D | 1 |
| Giordano, M | 1 |
| Ford, LM | 1 |
| Shipley, MT | 1 |
| Rao, KV | 2 |
| Puri, VN | 2 |
| el-Sawaf, HA | 1 |
| McMillen, BA | 1 |
| Scott, SM | 1 |
| Williams, HL | 1 |
| Diwan, PK | 1 |
| Alvarez, FM | 1 |
| Brown, F | 1 |
| Campbell, W | 1 |
| Clark, MS | 1 |
| Graves, DS | 1 |
| Hadley, MS | 1 |
| Hatcher, J | 1 |
| Mitchell, P | 1 |
| Needham, P | 1 |
| Riley, G | 1 |
| Semple, J | 1 |
| Martin, GE | 1 |
| Elgin, RJ | 1 |
| Kesslick, JM | 1 |
| Baldy, WJ | 1 |
| Mathiasen, JR | 1 |
| Shank, RP | 1 |
| Scott, MK | 1 |
| Jakovlev, V | 1 |
| Achterrath-Tuckermann, U | 1 |
| von Schlichtegroll, A | 1 |
| Stroman, F | 1 |
| Thiemer, K | 1 |
| Burak, K | 1 |
| Lipnicka, U | 1 |
| Orszańska, H | 1 |
| Rykowski, Z | 1 |
| Witkiewicz, K | 1 |
| Wrzesień, J | 1 |
| Bogdal, M | 1 |
| Krzywasiński, L | 1 |
| Borkowska, B | 1 |
| Sayers, AC | 2 |
| Handley, SL | 2 |
| Julou, L | 3 |
| Bourat, G | 1 |
| Ducrot, R | 1 |
| Fournel, J | 1 |
| Garret, C | 1 |
| Vagne, A | 1 |
| Vigier, J | 1 |
| Boucherle, A | 1 |
| Klawans, HL | 1 |
| Goetz, C | 1 |
| Westheimer, R | 1 |
| Marsden, CA | 1 |
| Guldberg, HC | 1 |
| Gumulka, W | 1 |
| Kostowski, W | 2 |
| Czlonkowski, A | 2 |
| Boissier, JR | 3 |
| Simon, P | 3 |
| Villeneuve, A | 2 |
| Larousse, C | 1 |
| Dresse, A | 1 |
| Lenaerts, FM | 1 |
| Pinchard, A | 1 |
| Schaper, WK | 1 |
| van Nueten, JM | 1 |
| Verbruggen, FJ | 1 |
| Theobald, W | 2 |
| Büch, O | 1 |
| Delini-Stula, A | 2 |
| Eigenmann, R | 1 |
| Levin, P | 1 |
| Olley, JE | 2 |
| Ueki, S | 1 |
| Ogawa, N | 1 |
| Watanabe, S | 1 |
| Gomita, Y | 1 |
| Araki, Y | 1 |
| Cashin, CH | 1 |
| Sutton, S | 1 |
| Grabowska, M | 1 |
| Zetler, G | 1 |
| Thörner, R | 1 |
| Moller Nielsen, I | 2 |
| Fjalland, B | 1 |
| Nymark, M | 1 |
| Tseng, LF | 1 |
| Loh, HH | 1 |
| Kuhn, R | 1 |
| Taeschler, M | 1 |
| Schoch, J | 1 |
| Grunfeld, Y | 1 |
| Edery, H | 1 |
| Randrup, A | 2 |
| Pakkenberg, H | 2 |
| Konieczny, M | 1 |
| Teodorczyk, J | 1 |
| Wagner, E | 1 |
| Sayers, A | 1 |
| Spencer, PS | 1 |
| Etevenon, P | 1 |
| Piarroux, MC | 1 |
| Sharma, VN | 1 |
| Mital, RL | 1 |
| Banerjee, SP | 1 |
| Sharma, HL | 1 |
| György, L | 1 |
| Pfeifer, KA | 1 |
| Hajtman, B | 1 |
| Pálosi, E | 1 |
| Mészáros, C | 1 |
| Szporny, L | 1 |
| Hester, JB | 1 |
| Rudzik, AD | 1 |
| Keasling, HH | 1 |
| Veldkamp, W | 1 |
| Arnold, OH | 1 |
| Collard, J | 1 |
| Deniker, P | 1 |
| Ginestet, D | 1 |
| Hippius, H | 1 |
| Itil, TM | 1 |
| Labhardt, F | 1 |
| Leeds, AA | 1 |
| Montanini, R | 1 |
| Morozov, G | 1 |
| Van Rossum, JM | 1 |
| Loew, DM | 1 |
| Munkvad, I | 1 |
| Stille, G | 2 |
| Tedeschi, DH | 1 |
| Morpurgo, C | 2 |
4 reviews available for amphetamine and Anochlesia
| Article | Year |
|---|---|
The role of excitatory amino acids in experimental models of Parkinson's disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Catalepsy; Disease M | 1994 |
Pathophysiology of schizophrenia and the striatum.
Topics: Adult; Amphetamine; Animals; Basal Ganglia; Catalepsy; Caudate Nucleus; Dihydroxyphenylalanine; Dopa | 1972 |
On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats.
Topics: Amphetamine; Animals; Basal Ganglia; Caffeine; Catalepsy; Cocaine; Compulsive Behavior; Corpus Stria | 1972 |
[Compounds stimulating central catecholamine receptors].
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain; Catalepsy; Catecholamines; C | 1973 |
1 trial available for amphetamine and Anochlesia
| Article | Year |
|---|---|
[Pharmacologic and clinical properties of a new butyrophenone derivative (FR 33)].
Topics: Adult; Amphetamine; Animals; Antidepressive Agents; Butyrophenones; Catalepsy; Catatonia; Clinical T | 1966 |
132 other studies available for amphetamine and Anochlesia
| Article | Year |
|---|---|
Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Catalepsy; Dizocilpine Maleate; Dop | 2022 |
Behavioral effects induced by the cannabidiol analogs HU-502 and HU-556.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Cannabidiol; | 2023 |
Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophrenia.
Topics: Amphetamine; Animals; Apomorphine; Arginine; Behavior, Animal; Catalepsy; Disease Models, Animal; Di | 2021 |
Behavioural and functional characterization of Kv10.1 (Eag1) knockout mice.
Topics: Action Potentials; Amphetamine; Animals; Antidepressive Agents; Behavior, Animal; Brain; Catalepsy; | 2013 |
Lunasin-induced behavioural effects in mice: focus on the dopaminergic system.
Topics: Amphetamine; Animals; Apomorphine; Bicuculline; Brain; Catalepsy; Central Nervous System Agents; Cyc | 2013 |
Selective effects of D- and L-govadine in preclinical tests of positive, negative, and cognitive symptoms of schizophrenia.
Topics: Alzheimer Disease; Amphetamine; Animals; Antipsychotic Agents; Avoidance Learning; Berberine Alkaloi | 2014 |
Effects of dehydroepiandrosterone in amphetamine-induced schizophrenia models in mice.
Topics: Adjuvants, Immunologic; Amphetamine; Animals; Apomorphine; Catalepsy; Central Nervous System Stimula | 2014 |
A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effects.
Topics: Amphetamine; Animals; Antipsychotic Agents; Arrestins; beta-Arrestins; Brain; Catalepsy; Clathrin; G | 2014 |
Amphetamine and morphine may produce acute-withdrawal related hypoactivity by initially activating a common dopamine pathway.
Topics: Amphetamine; Animals; Benzazepines; Catalepsy; Disease Models, Animal; Dopamine; Dopamine Agents; Dr | 2016 |
The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonist.
Topics: Amphetamine; Animals; Antipsychotic Agents; Avoidance Learning; Berberine; Brain Chemistry; Cataleps | 2008 |
Feeding conditions differentially affect the neurochemical and behavioral effects of dopaminergic drugs in male rats.
Topics: Amphetamine; Animals; Behavior, Animal; Blood Glucose; Body Weight; Brain Chemistry; Caloric Restric | 2008 |
Prenatal protein deprivation alters dopamine-mediated behaviors and dopaminergic and glutamatergic receptor binding.
Topics: Age Factors; Amphetamine; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Catalep | 2008 |
BL-1020: a novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia.
Topics: Acetylcholine; Amphetamine; Animals; Antipsychotic Agents; Biological Availability; Brain; Catalepsy | 2009 |
Evaluation of amphetamine-induced hyperlocomotion and catalepsy following long-acting risperidone administration in rats.
Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Chemistry, Pharmaceutical; | 2009 |
The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice.
Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Clozapine | 2010 |
Pitx3-deficient aphakia mice display unique behavioral responses to psychostimulant and antipsychotic drugs.
Topics: Amphetamine; Analysis of Variance; Animals; Aphakia; Apomorphine; Behavior, Animal; Catalepsy; Corpu | 2010 |
AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents.
Topics: Acoustic Stimulation; Amphetamine; Animals; Antipsychotic Agents; Anxiety; Behavior, Animal; Catalep | 2011 |
Antipsychotic property of aqueous and ethanolic extracts of Lonchocarpus cyanescens (Schumach and Thonn.) Benth. (Fabaceae) in rodents.
Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Chlorpromazine; Chromatogra | 2012 |
Reversal of oxidative stress by histamine H₃ receptor-ligands in experimental models of schizophrenia.
Topics: Amphetamine; Animals; Antioxidants; Antipsychotic Agents; Apomorphine; Behavior, Animal; Brain Chemi | 2012 |
Anti-psychotic and sedative effect of calcium channel blockers in mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Calcium Channel Blockers; Catalepsy; Disease Models, Ani | 2010 |
Cyclooxygenase inhibitor modulation of dopamine-related behaviours.
Topics: Amphetamine; Animals; Behavior, Animal; Benzazepines; Brain; Catalepsy; Cyclooxygenase 2; Cyclooxyge | 2002 |
Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 2: asymmetric synthesis and biological evaluation.
Topics: Amphetamine; Animals; Antipsychotic Agents; Binding, Competitive; Catalepsy; Central Nervous System | 2002 |
Newer substituted benzoxazepinyl-quinazolinones as potent antipsychotic and anticonvulsant agents.
Topics: Amphetamine; Animals; Anticonvulsants; Antipsychotic Agents; Catalepsy; Central Nervous System Stimu | 2003 |
[EFFECT OF VARIOUS PHARMACOLOGICAL AGENTS ON CATALEPTIC SYMPTOMS IN CATATONIC STUPOR].
Topics: Amphetamine; Amphetamines; Catalepsy; Catatonia; Chlorpromazine; Humans; Reserpine; Stupor | 1963 |
IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Drug Hypersensitiv | 1965 |
CENTRAL NERVOUS SYSTEM DEPRESSANT ACTIVITY OF MA1337, 3-(3-(4-M-CHLOROPHENYL-1-PIPERAZYL)PROPYL)-2,4(1H,3H)QUINAZOLINEDIONE HYDROCHLORIDE.
Topics: Amphetamine; Amphetamines; Behavior, Animal; Body Temperature; Catalepsy; Cats; Central Nervous Syst | 1965 |
Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
Topics: Amphetamine; Animals; Behavior, Animal; Blood Glucose; Blood-Brain Barrier; Body Temperature; Brain; | 2003 |
FAUC 213, a highly selective dopamine D4 receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia.
Topics: Amphetamine; Animals; Brain; Catalepsy; Chromatography, High Pressure Liquid; Disease Models, Animal | 2004 |
Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Basal | 2004 |
Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation.
Topics: Amphetamine; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Body Weight; Brain; | 2004 |
Cinnarizine has an atypical antipsychotic profile in animal models of psychosis.
Topics: Amphetamine; Animals; Antipsychotic Agents; Calcium Channel Blockers; Catalepsy; Central Nervous Sys | 2005 |
Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dose-Response Relationship, Drug | 2006 |
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties.
Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Binding, Competitive; Bi | 2006 |
D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD.
Topics: Adenylyl Cyclases; Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Catalepsy; C | 2007 |
ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Brain Chemistry; Catalep | 2007 |
ST2472: a new potential antipsychotic with very low liability to induce side-effects.
Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Anim | 2008 |
Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Central Nervous System Stimulan | 2008 |
Dysregulation of the mesolimbic dopamine system and reward in MCH-/- mice.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Catalepsy; Dopamine; Dopamine Antagoni | 2008 |
Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments.
Topics: Amphetamine; Animals; Apomorphine; Catalepsy; Excitatory Amino Acid Antagonists; Haloperidol; Ketami | 2008 |
MIF (Pro-Leu-Gly-NH2): failure to affect oxotremorine effects in mice and rats as well as fluphenazine catalepsy or amphetamine hyperactivity in rats.
Topics: Amphetamine; Animals; Catalepsy; Fluphenazine; Humans; Male; Mice; Motor Activity; MSH Release-Inhib | 1980 |
Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics.
Topics: Amphetamine; Animals; Antipsychotic Agents; Catalepsy; Humans; Isoxazoles; Male; Oxazoles; Rats; Sco | 1981 |
Is dopamine antagonism a requisite of neuroleptic activity?
Topics: Amphetamine; Animals; Antipsychotic Agents; Avoidance Learning; Blepharoptosis; Brain Chemistry; Cat | 1980 |
[Effect of psychotropic drugs on the central dopamine metabolism (example: neuroleptics)].
Topics: Adenylyl Cyclases; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Brain; Catalepsy; Cats; | 1981 |
Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats.
Topics: Amphetamine; Analgesics; Analgesics, Opioid; Animals; Apomorphine; Catalepsy; Codeine; Dopamine; Dru | 1981 |
Pharmacological effects of Ro 22-1319: a new antipsychotic agent.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Autonomic Nervous System; Avoidance Learnin | 1983 |
Aminoalkylindoles: atypical dopamine antagonists.
Topics: Amphetamine; Animals; Antipsychotic Agents; Catalepsy; Corpus Striatum; Dopamine Antagonists; Halope | 1983 |
Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Antipsychotic Agen | 1984 |
Reticuline: a dopamine receptor blocker.
Topics: Alkaloids; Amphetamine; Animals; Apomorphine; Behavior, Animal; Benzylisoquinolines; Catalepsy; Dopa | 1980 |
Behavioural and biochemical changes following chronic administration of L-dopa to rats.
Topics: Adenylyl Cyclases; Amphetamine; Animals; Behavior, Animal; Binding, Competitive; Brain Chemistry; Ca | 1982 |
Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability.
Topics: Amphetamine; Animals; Antipsychotic Agents; Catalepsy; Clozapine; Disease Models, Animal; Extrapyram | 1995 |
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Topics: Adenylyl Cyclases; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Biogen | 1995 |
Chemical and pharmacological properties of new tetrahydropyrimido-[2,1-f]-purines.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anticonvulsants; Antipsychotic Agents; Body Temperature; | 1995 |
Croton zehntneri: possible central nervous system effects of the essential oil in rodents.
Topics: Amphetamine; Animals; Anticonvulsants; Behavior, Animal; Brazil; Catalepsy; Croton Oil; Male; Mice; | 1995 |
The influence of antineoplaston A5 on the central dopaminergic structures.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain; Catalepsy; Dopamine; Haloperidol; Male; | 1994 |
Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drug.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Basal Ganglia Diseases; | 1993 |
Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
Topics: 4-Butyrolactone; Adenylyl Cyclases; Amphetamine; Animals; Apomorphine; Biogenic Monoamines; Brain; C | 1993 |
Effects of remoxipride's metabolites on dopamine D2 receptors and receptor functions in the rat.
Topics: Amphetamine; Animals; Apomorphine; Catalepsy; Hypothermia; In Vitro Techniques; Male; Motor Activity | 1993 |
Lisuride reduces psychomotor retardation during withdrawal from chronic intravenous amphetamine self-administration in rats.
Topics: Amphetamine; Animals; Catalepsy; Lisuride; Male; Motor Activity; Rats; Rats, Wistar; Self Administra | 1993 |
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Brain; Catalepsy; Cloza | 1996 |
Locomotor and passive avoidance deficits following occlusion of the middle cerebral artery.
Topics: Acetylcholinesterase; Amphetamine; Animals; Avoidance Learning; Brain; Catalepsy; Central Nervous Sy | 1995 |
1S,3R-ACPD has cataleptogenic effects and reverses MK-801-, and less pronounced, D,L-amphetamine-induced locomotion.
Topics: Amphetamine; Animals; Catalepsy; Cycloleucine; Dizocilpine Maleate; Dose-Response Relationship, Drug | 1996 |
NNC-19-1228 and NNC 22-0031, novel neuroleptics with a "mesolimbic-selective" behavioral profile.
Topics: Amphetamine; Animals; Antipsychotic Agents; Avoidance Learning; Benzothiazoles; Benzoxazoles; Carbam | 1997 |
Antipsychotic-like profile of alstonine.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Catalepsy; Drug Evaluatio | 1998 |
The mGluRs group II agonist (2S,3S,4S)-alpha-carboxycyclopropyl-glycine induces catalepsy in the rat, which is pronouncedly antagonised by dizocilpine and D,L-amphetamine.
Topics: Amino Acids, Dicarboxylic; Amphetamine; Animals; Catalepsy; Cerebral Ventricles; Dizocilpine Maleate | 1998 |
Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine.
Topics: Amphetamine; Animals; Catalepsy; Caudate Nucleus; Cocaine; Dopamine; Drug Interactions; Grooming; Ma | 1999 |
Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzamides; Catalepsy; Cells, Cultured; Cyclic AMP; Dopa | 1999 |
GABAergic involvement in motor effects of an adenosine A(2A) receptor agonist in mice.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Amphetamine; Animals; Catalepsy; Dopamine Agents; GABA | 2000 |
[The effect of lithium chloride on the rat behavior after short-term oligemic hypoxia].
Topics: Amphetamine; Animals; Behavior, Animal; Brain; Catalepsy; Drug Synergism; Haloperidol; Ischemic Atta | 1998 |
Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D(3) receptor deficient mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Brain; Catalepsy; Cocaine; Dopamine Uptake Inhibitors; F | 2001 |
Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity.
Topics: Amphetamine; Animals; Body Temperature; Catalepsy; Central Nervous System Stimulants; Dose-Response | 2001 |
The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Catalepsy; Conditioning, Ps | 2002 |
The neuropharmacological actions of amoxapine.
Topics: Amoxapine; Amphetamine; Animals; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Behavi | 1978 |
Assessment of the neuroleptic potential of some novel benzamide, butyrophenone, phenothiazine and indole derivatives.
Topics: Amphetamine; Animals; Antipsychotic Agents; Benzamides; Butyrophenones; Catalepsy; Dopamine Antagoni | 1978 |
Psychopharmacological studies on (--)-nuciferine and its Hofmann degradation product atherosperminine.
Topics: Amphetamine; Analgesia; Animals; Anticonvulsants; Aporphines; Avoidance Learning; Behavior, Animal; | 1978 |
A comparison of the central actions of prostaglandins A1, E1, E2, F1alpha, and F2alpha in the rat. II. The effect of intraventricular prostaglandins on the action of some drugs and on the level and turnover of biogenic amines in the rat brain.
Topics: Acetylcholine; Amphetamine; Animals; Biogenic Amines; Body Temperature; Brain; Catalepsy; Chlorproma | 1976 |
A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity.
Topics: Aggression; Amphetamine; Analgesics, Opioid; Animals; Apomorphine; Behavior, Animal; Brain; Cataleps | 1975 |
Amphetamine-haloperidol interactions in rat striatum: failure to correlate behavioral effects with dopaminergic and cholinergic dynamics.
Topics: Amphetamine; Animals; Behavior, Animal; Catalepsy; Choline; Corpus Striatum; Dopamine; Drug Interact | 1977 |
Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Brain Chemistry; Brain Stem; Catalepsy; Cerebellum; Cer | 1977 |
Presynaptic subsensitivity as a possible basis for sensitization by long-term dopamine mimetics.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Catalepsy; Dopamine; Humans; Male; Protein Bind | 1979 |
Interaction of promethazine with neuroleptic drugs.
Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Catalepsy; Chlorpromazine; Conditioning, Psycholog | 1979 |
Morphine-induced catalepsy in the rat: effect on striatal acetylcholine & cholinesterase.
Topics: Acetylcholine; Amphetamine; Animals; Catalepsy; Cholinesterases; Corpus Striatum; Drug Interactions; | 1979 |
The pharmacology of a new potent, long acting neuroleptic, piflutixol.
Topics: Adenylyl Cyclases; Amphetamine; Anesthesia; Animals; Apomorphine; Arousal; Barbiturates; Behavior, A | 1977 |
Differential attenuation of some effects of haloperidol in rats given scopolamine.
Topics: Amphetamine; Animals; Avoidance Learning; Catalepsy; Corpus Striatum; Dose-Response Relationship, Dr | 1976 |
Neuroleptic action of clozapine injected into various brain areas in rats.
Topics: Amphetamine; Animals; Brain; Catalepsy; Cerebral Cortex; Chlorpromazine; Clozapine; Corpus Striatum; | 1975 |
The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Catalepsy; Chlorpromazine; | 1975 |
Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists.
Topics: Amphetamine; Animals; Behavior, Animal; Benzazepines; Benzofurans; Catalepsy; Dopamine; Male; Mice; | 1992 |
Lesions of the tegmental pedunculopontine nucleus: effects on the locomotor activity induced by morphine and amphetamine.
Topics: Amphetamine; Animals; Catalepsy; Male; Morphine; Motor Activity; Naloxone; Pons; Rats; Rats, Inbred | 1992 |
Neural grafts and pharmacological intervention in a model of Huntington's disease.
Topics: Acetylcholinesterase; Amphetamine; Animals; Brain Tissue Transplantation; Catalepsy; Cerebral Cortex | 1990 |
Further studies on the neuroleptic profile of manassantin A.
Topics: Adenylyl Cyclase Inhibitors; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Binding, | 1990 |
Effects of subchronic amphetamine or amfonelic acid on rat brain dopaminergic and serotonergic function.
Topics: Amphetamine; Animals; Brain Chemistry; Catalepsy; Dopamine; Down-Regulation; Drug Interactions; Halo | 1991 |
Preliminary evaluation of manassantin A, a potential neuroleptic agent from Saururus cernuus.
Topics: Amphetamine; Animals; Antipsychotic Agents; Blepharoptosis; Body Temperature; Catalepsy; Furans; Hal | 1987 |
The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide.
Topics: Adenylyl Cyclase Inhibitors; Amphetamine; Animals; Apomorphine; Avoidance Learning; Benzamides; Brai | 1988 |
Block of conditioned avoidance responding in the rat by substituted phenylpiperazines.
Topics: Amphetamine; Animals; Avoidance Learning; Behavior, Animal; Catalepsy; Conditioning, Psychological; | 1988 |
[General pharmacologic studies on the analgesic flupirtine].
Topics: Aminopyridines; Amphetamine; Analgesics; Animals; Anticonvulsants; Catalepsy; Central Nervous System | 1985 |
Synthesis of new arylanalogs of ketamine.
Topics: Amphetamine; Analgesics; Animals; Anticonvulsants; Behavior, Animal; Blepharoptosis; Body Temperatur | 1985 |
A study of the role of catecholamines in the response to various central stimulants.
Topics: Amphetamine; Animals; Apomorphine; Catalepsy; Catecholamines; Central Nervous System Stimulants; Coc | 1973 |
Pharmacological study of pipotiazine (19.366 R.P.) and its undecylenic (19.551 R.P.) and palmitic (19.552 R.P.) esters.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dogs; Esters; Fluphenazine; Guin | 1973 |
Neuroleptics: relation between cataleptic and anti-turning actions, and role of the cholinergic system.
Topics: Amphetamine; Animals; Behavior; Catalepsy; Chlorpromazine; Humans; Parasympathetic Nervous System; P | 1974 |
[Action on the central nervous system of NN'-diphenylacetamidine and its salts].
Topics: Acetamides; Acetates; Amidines; Amphetamine; Animals; Body Temperature; Catalepsy; Central Nervous S | 1970 |
The role of monoamines in rotation induced or potentiated by amphetamine after nigral, raphe and mesencephalic reticular lesions in the rat brain.
Topics: Amines; Amphetamine; Animals; Behavior, Animal; Brain; Brain Injuries; Catalepsy; Cerebral Cortex; C | 1973 |
Role of 5-HT in the action of some drugs affecting extrapyramidal system.
Topics: Amphetamine; Animals; Brain; Catalepsy; Chlorpromazine; Electrodes; Extrapyramidal Tracts; Female; F | 1973 |
Flurothyl in mice: seizure, post-convulsive behavior, and interactions with psychotropic drugs.
Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Biperiden; Caffeine; Catalepsy; Central Nervous Sy | 1968 |
Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Benzimidazoles; Blepharoptosis; Body Temperatur | 1968 |
[Pharmacological studies on the effect of neuroleptics in animals after single and repeated application].
Topics: Amphetamine; Animals; Apomorphine; Body Temperature; Catalepsy; Cats; Chlorpromazine; Conditioning, | 1968 |
Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
Topics: Administration, Oral; Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Bleph | 1974 |
Modification of the behavioural changes induced by amphetamine in the rat by lesions in the caudate nucleus, the caudate-putamen and globus pallidus.
Topics: Amphetamine; Animals; Basal Ganglia; Behavior, Animal; Catalepsy; Caudate Nucleus; Extrapyramidal Tr | 1972 |
[Psychopharmacological effects of doxepin hydrochloride].
Topics: Amitriptyline; Amphetamine; Animals; Behavior, Animal; Blepharoptosis; Body Temperature; Brain Chemi | 1972 |
The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
Topics: Amantadine; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Benztropine; Brain | 1973 |
Drug-induced catalepsy as influenced by psychostimulants, apomorphine, L-dopa, and yohimbine.
Topics: Amphetamine; Animals; Apomorphine; Catalepsy; Dihydroxyphenylalanine; Hallucinogens; Haloperidol; Hu | 1973 |
The activity of some neuroleptic drugs and amphetamine in normal and isolated rats.
Topics: Aggression; Amphetamine; Animals; Brain; Catalepsy; Chlorpromazine; Dopamine; Haloperidol; Humans; M | 1973 |
Catalepsy induced by alpha-methyl-p-tyrosine and d-amphetamine: the rôle of catecholamine metabolism.
Topics: Amphetamine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Catalepsy; Catechol O-Methyltran | 1974 |
Pharmacology of neuroleptics upon repeated administration.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Catalepsy; Cross Reactions; Dose-Response Rel | 1974 |
Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
Topics: Amphetamine; Animals; Apomorphine; Aporphines; Catalepsy; Dextroamphetamine; Dopamine; Haloperidol; | 1974 |
Psychopharmacological activity of the active constituents of hashish and some related cannabinoids.
Topics: Alkaloids; Amphetamine; Animals; Ataxia; Avoidance Learning; Behavior, Animal; Benzopyrans; Cannabis | 1969 |
Stereotypic and anticataleptic activities of amphetamine after intracerebral injections.
Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Catalepsy; Caudate Nucleus; Drug Interactions; Glo | 1972 |
Intrastriatal injection of quaternary butyrophenones and oxypertine: neuroleptic effect in rats.
Topics: Amphetamine; Animals; Basal Ganglia; Behavior, Animal; Brain; Butyrophenones; Catalepsy; Hippocampus | 1971 |
Intracerebral lesions causing stereotyped behaviour in rats.
Topics: Amphetamine; Animals; Basal Ganglia; Behavior, Animal; Brain Injuries; Catalepsy; Catheterization; D | 1971 |
Ipronal analogues. Synthesis, chemical and pharmacologic properties of 5-allyl-5-(beta-hydroxypropyl)-2-thio- and-2-iminobarbituric acids.
Topics: Amphetamine; Animals; Antidepressive Agents; Barbiturates; Catalepsy; Drug Antagonism; Drug Synergis | 1971 |
Effect of some amphetamine analogues on -methyl-p-tyrosine-induced catalepsy in rats.
Topics: Amphetamine; Animals; Benzene Derivatives; Catalepsy; Drug Synergism; Ephedrine; Female; Humans; Met | 1971 |
Effects of apomorphine and amphetamine in rats with a permanent catalepsy induced by diencephalic lesion.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Catalepsy; Diencephalon; Humans; Male; Rats; Ti | 1971 |
Pharmacological studies with some newly synthesized phenothiazines exhibiting lesser extrapyramidal reactions.
Topics: Aggression; Amphetamine; Animals; Behavior, Animal; Catalepsy; Central Nervous System; Chemical Phen | 1969 |
Modification of certain central nervous effects of haloperidol during long-term treatment in the mouse and rat.
Topics: Amphetamine; Animals; Brain; Catalepsy; Central Nervous System; Dopamine; Drug Synergism; Female; Ha | 1969 |
Pharmacological studies with N-3,4,5-trimethoxybenzoyl-heptamethylene imine (N-1157), a new antidepressant agent.
Topics: Amphetamine; Animals; Antidepressive Agents; Ataxia; Blood Pressure; Body Temperature; Catalepsy; Ca | 1969 |
4'-Fluoro-4-(1,4,5,6-tetrahydroazepinol[4,5-b]indol-3(2H)-yl)butyrophenones.
Topics: Amphetamine; Animals; Apomorphine; Azepines; Blepharoptosis; Body Temperature; Butyrophenones; Catal | 1970 |
Behavioural effects in rats of morphine and amphetamine and of a combination of the two drugs.
Topics: Amphetamine; Animals; Behavior, Animal; Catalepsy; Drug Antagonism; Grooming; Humans; Locomotion; Ma | 1970 |
Definition and classification of neuroleptics.
Topics: Amphetamine; Animals; Apomorphine; Autonomic Nervous System; Basal Ganglia Diseases; Behavior; Catal | 1970 |
The neuroleptics. 3. Pharmacology. Introduction.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior; Behavior, Animal; Blepharoptosis; B | 1970 |
On the interaction between neuroleptics and antiparkinson drugs.
Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Behavior, Animal; C | 1970 |
Neurophysiological substrates of the pharmacological criteria for neuroleptics.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Catalepsy; Caudate Nucleus; Corpus Striatum; Co | 1970 |
Chemical and pharmacological classification of neuroleptics.
Topics: Amphetamine; Aniline Compounds; Animals; Apomorphine; Behavior, Animal; Blepharoptosis; Butylamines; | 1970 |
Influence of amphetamine and scopolamine on the catalepsy induced by diencephalic lesions in rats.
Topics: Amphetamine; Animals; Avoidance Learning; Catalepsy; Electric Stimulation; Humans; Hypothalamus; Mal | 1968 |
Influence of antiparkinson drugs and amphetamine on some pharmacological effects of phenothiazine derivatives used as neuroleptics.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Body Temperature; Catalepsy | 1964 |